Literature DB >> 17367575

Dietary non-digestible carbohydrates promote L-cell differentiation in the proximal colon of rats.

Patrice D Cani1, Sophie Hoste, Yves Guiot, Nathalie M Delzenne.   

Abstract

One of the challenges in type 2 diabetes treatment is to ensure pancreas functionality with gut peptides such as glucagon-like peptide-1 (GLP-1). We have recently shown that the endogenous GLP-1 production is promoted by dietary non-digestible carbohydrates (oligofructose), the higher GLP-1 secretion could participate in the control of obesity and associated disorders. This experimental study was designed to highlight the mechanisms of endogenous increase of GLP-1 following non-digestible carbohydrate feeding. Male Wistar rats were fed a standard diet (70.4 g/100 g total carbohydrates; controls) or the same diet supplemented with oligofructose (10 g/100 g diet) for 4 weeks. GLP-1-producing L-cells of the colon were quantified by immunohistochemistry. GLP-1 was quantified by ELISA, and proglucagon, neurogenin 3 and NeuroD mRNA were measured in the colon by quantitative RT-PCR. The number of GLP-1-expressing cells was doubled in the proximal colon of oligofructose-treated rats, a phenomenon correlated with the increase in proglucagon mRNA and peptide content in the tissue. Moreover, oligofructose increased the number of enteroendocrine L-cells in the proximal colon by a mechanism involving up-regulation of two differentiation factors: neurogenin 3 and NeuroD. It is the first demonstration that nutrients fermented in the gut may promote L-cell differentiation in the proximal colon, a phenomenon contributing to a higher endogenous GLP-1 production. These results suggest a new mechanism by which dietary fibres may lower food intake and fat mass development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17367575     DOI: 10.1017/S0007114507691648

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  78 in total

1.  Fructose malabsorption induces cholecystokinin expression in the ileum and cecum by changing microbiota composition and metabolism.

Authors:  Xufei Zhang; Alexandra Grosfeld; Edek Williams; Daniel Vasiliauskas; Sharon Barretto; Lorraine Smith; Mahendra Mariadassou; Catherine Philippe; Fabienne Devime; Chloé Melchior; Guillaume Gourcerol; Nathalie Dourmap; Nicolas Lapaque; Pierre Larraufie; Hervé M Blottière; Christine Herberden; Philippe Gerard; Jens F Rehfeld; Ronaldo P Ferraris; J Christopher Fritton; Sandrine Ellero-Simatos; Veronique Douard
Journal:  FASEB J       Date:  2019-04-02       Impact factor: 5.191

Review 2.  Classification and functions of enteroendocrine cells of the lower gastrointestinal tract.

Authors:  Ashok R Gunawardene; Bernard M Corfe; Carolyn A Staton
Journal:  Int J Exp Pathol       Date:  2011-04-25       Impact factor: 1.925

Review 3.  Gut microbiota: a key player in health and disease. A review focused on obesity.

Authors:  M J Villanueva-Millán; P Pérez-Matute; J A Oteo
Journal:  J Physiol Biochem       Date:  2015-03-08       Impact factor: 4.158

Review 4.  Glucose transporters in the small intestine in health and disease.

Authors:  Hermann Koepsell
Journal:  Pflugers Arch       Date:  2020-08-23       Impact factor: 3.657

5.  Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia.

Authors:  P D Cani; A M Neyrinck; F Fava; C Knauf; R G Burcelin; K M Tuohy; G R Gibson; N M Delzenne
Journal:  Diabetologia       Date:  2007-09-06       Impact factor: 10.122

6.  Effect of catch-up growth after food restriction on the entero-insular axis in rats.

Authors:  Lu-Lu Chen; Wei-Hong Yang; Juan Zheng; Xiang Hu; Wen Kong; Hao-Hao Zhang
Journal:  Nutr Metab (Lond)       Date:  2010-05-26       Impact factor: 4.169

Review 7.  Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded?

Authors:  Giovanni Musso; Roberto Gambino; Maurizio Cassader
Journal:  Diabetes Care       Date:  2010-10       Impact factor: 19.112

Review 8.  Gut microbiome and metabolic diseases.

Authors:  Shinji Fukuda; Hiroshi Ohno
Journal:  Semin Immunopathol       Date:  2013-11-06       Impact factor: 9.623

9.  Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability.

Authors:  P D Cani; S Possemiers; T Van de Wiele; Y Guiot; A Everard; O Rottier; L Geurts; D Naslain; A Neyrinck; D M Lambert; G G Muccioli; N M Delzenne
Journal:  Gut       Date:  2009-02-24       Impact factor: 23.059

Review 10.  The environment within: how gut microbiota may influence metabolism and body composition.

Authors:  A Vrieze; F Holleman; E G Zoetendal; W M de Vos; J B L Hoekstra; M Nieuwdorp
Journal:  Diabetologia       Date:  2010-01-26       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.